for educational and safety purposes
Every compound in the sci-wiki that affects pain signaling; the ones you can source are floated to the front, then the reference-only entries. Tap any for the full entry, mechanism, and outlets.
0 sourced · 2 reference
ADL-5747 is an investigational, orally active, selective delta (delta) opioid receptor agonist that was developed as a non-classical analgesic. It progressed into clinical testing but development was discontinued after failing to advance past Phase II.
ART27-13 (also written ART27.13) is an experimental, orally active cannabinoid drug that acts as a potent, peripherally selective full agonist of the CB1 and CB2 cannabinoid receptors. Originally developed by AstraZeneca as AZD1940 and studied for pain, it is now being developed by Artelo Biosciences as a supportive treatment for cancer-related anorexia and cachexia, the syndrome of appetite loss and muscle wasting.